The capsule of Bacillus anthracis protects it from the bactericidal activity of human defensins and other cationic antimicrobial peptides.
During infection, Bacillus anthracis bacilli encounter potent antimicrobial peptides (AMPs) such as defensins. We examined the role that B. anthracis capsule plays in protecting bacilli from defensins and other cationic AMPs by comparing their effects on a fully virulent encapsulated wild type (WT)...
Main Authors: | David K O'Brien, Wilson J Ribot, Donald J Chabot, Angelo Scorpio, Steven A Tobery, Tanya M Jelacic, Zhibin Wu, Arthur M Friedlander |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2022-09-01
|
Series: | PLoS Pathogens |
Online Access: | https://doi.org/10.1371/journal.ppat.1010851 |
Similar Items
-
Activity of the <it>Bacillus anthracis </it>20 kDa protective antigen component
by: Jett Marti, et al.
Published: (2008-09-01) -
Capsules, toxins and AtxA as virulence factors of emerging Bacillus cereus biovar anthracis.
by: Christophe Brézillon, et al.
Published: (2015-04-01) -
Anthrax, but not Bacillus anthracis?
by: Richard Okinaka, et al.
Published: (2006-11-01) -
Etymologia: Bacillus anthracis
Published: (2014-09-01) -
Ruling Out Bacillus anthracis
by: Joseph Papaparaskevas, et al.
Published: (2004-04-01)